Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

How are validities (lifecycles phases) assigned in Biomarkers Knowledge Area?

April 26, 2017area biomarkers knowledge lifecycles phases validities

0

Posted

How are validities (lifecycles phases) assigned in Biomarkers Knowledge Area?

1 Answer

0

Posted

The highest validity corresponding to each use of a biomarker has to be assigned. This means if a use is reported in papers with results from clinical trials in different phases but the same use is described in a clinical practice guideline, the use will be assigned the validity status “Recommended/approved”.